Conference call report on operations

Conference call report on operations

Invitation to attend Vitrolife's conference call regarding presentation of the
report on operations for 2007. The presentation will be held in Swedish.

Time: Thursday, February 7, 2008 at 3.30 p.m. CET.
Telephone number: +46 8 505 201 14
Conference name: Vitrolife

Vitrolife participants:
Magnus Nilsson, CEO
Anna Ahlberg, CFO

The press release for Vitrolife's report on operations will be released in good
time before 3.30 p.m. CET on February 7. 

Before the conference call, slides will be available at the company web page,
www.vitrolife.com, under the section Investors/News (the Swedish page).

A recorded version of the presentation will be available for seven days on
number +46 8 505 203 33, access code 783057.











Queries should be addressed to: 
Anna Ahlberg, CFO, phone +46 31 721 80 13 or +46 708 22 80 13.


________________________________________________________________________________
_________
Vitrolife is a global biotechnology/medical device Group that works with
developing, manufacturing and selling advanced products and systems for the
preparation, cultivation and storage of human cells, tissue and organs. The
company has business activities within three product areas: Fertility,
Transplantation and Stem Cell Cultivation. The Fertility product area works with
nutrient solutions (media) and advanced consumable instruments such as needles
and pipettes, for the treatment of human infertility. The Transplantation
product area works with solutions and systems to maintain tissue in optimal
condition outside the body for the required time while waiting for
transplantation. The Stem Cell Cultivation product area works with media and
instruments to enable the use and handling of stem cells for therapeutic
purposes. 
     Vitrolife today has approximately 140 employees and the company's products
are sold in more than 80 markets. The head office is in Kungsbacka, Sweden, and
there are subsidiaries outside Gothenburg, Sweden and in Denver, USA. The
Vitrolife share is listed on the OMX Nordic Exchange's Nordic Small Cap list.
________________________________________________________________________________
_________
Vitrolife AB (publ), Faktorvägen 13, SE-434 37 Kungsbacka, Sweden. Corporate
identity number 556354-3452.
Tel: +46 31 721 80 00. Fax: +46 31 721 80 90. E-mail: info@vitrolife.com.
Homepage: www.vitrolife.com.